Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study

Title:	Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study
Authors:	Lynce, Filipa^{Aff1, Aff2, Aff3, IDs4146702446961x_cor1}; Mainor, Candace^Aff4; Donahue, Renee N.^Aff5; Geng, Xue^Aff6; Jones, Greg^Aff7; Schlam, Ilana^{Aff8, Aff9}; Wang, Hongkun^Aff6; Toney, Nicole J.^Aff5; Jochems, Caroline^Aff5; Schlom, Jeffrey^Aff5; Zeck, Jay^Aff4; Gallagher, Christopher^Aff8; Nanda, Rita^Aff10; Graham, Deena^Aff11; Stringer-Reasor, Erica M.^Aff12; Denduluri, Neelima^Aff13; Collins, Julie^{Aff4, Aff17}; Chitalia, Ami^Aff8; Tiwari, Shruti^Aff8; Nunes, Raquel^{Aff14, Aff17}; Kaltman, Rebecca^Aff15; Khoury, Katia^Aff12; Gatti-Mays, Margaret^Aff16; Tarantino, Paolo^{Aff1, Aff3}; Tolaney, Sara M.^{Aff1, Aff2, Aff3}; Swain, Sandra M.^Aff6; Pohlmann, Paula^Aff4; Parsons, Heather A.^{Aff1, Aff2, Aff3}; Isaacs, Claudine^Aff6
Source:	Nature Communications. 15(1)
Database:	Springer Nature Journals